Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 21;17(1):420.
doi: 10.1186/s13023-022-02570-9.

Diagnostic delay of myositis: an integrated systematic review

Affiliations

Diagnostic delay of myositis: an integrated systematic review

Tergel Namsrai et al. Orphanet J Rare Dis. .

Abstract

Background: Idiopathic inflammatory myopathies (IIM) are a heterogenous group of rare muscular autoimmune diseases characterised by skeletal muscle inflammation with possible diagnostic delay. Our aim was to review the existing evidence to identify overall diagnostic delay for IIM, factors associated with diagnostic delay, and people's experiences of diagnostic delay.

Methods: Three databases and grey literature sources were searched. Diagnostic delay was defined as the period between the onset of symptoms and the year of first diagnosis of IIM. We pooled the mean delay using random effects inverse variance meta-analysis and performed subgroup analyses.

Results: 328 titles were identified from which 27 studies were included. Overall mean diagnostic delay was 27.91 months (95% CI 15.03-40.79, I2 = 99%). Subgroup analyses revealed a difference in diagnostic delay between non-inclusion body myositis (IBM) and IBM types. There was no difference in diagnostic delay between studies in which myositis specific autoantibodies (MSA) were tested or not tested. In countries with gatekeeper health systems, where primary care clinicians authorize access to specialty care, people experienced longer periods of diagnostic delay than people with IIM in countries with non-gatekeeper systems. While studies discussed factors that may influence diagnostic delay, significant associations were not identified. No qualitative studies examining people's experiences of diagnostic delay were identified.

Conclusion: Diagnostic delay of IIM has extensive impacts on the quality of life of people living with this disease. Understanding the experiences of people with IIM, from symptom onset to diagnosis, and factors that influence diagnostic delay is critical to inform clinical practice and training activities aimed at increasing awareness of this rare disease and expediting diagnosis.

Trial registration: PROSPERO Registration number: CRD42022307236 URL of the PROSPERO registration: https://www.crd.york.ac.uk/PROSPEROFILES/307236_PROTOCOL_20220127.pdf.

Keywords: Diagnostic delay; Idiopathic inflammatory myositis; Meta-analysis; Myositis; Systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflict of interest.

Figures

Fig. 1
Fig. 1
Study selection flow chart
Fig. 2
Fig. 2
Forrest plot for mean diagnostic delay in all types of IIM
Fig. 3
Fig. 3
Forrest plot for all types of IIM
Fig. 4
Fig. 4
Forrest plot for mean diagnostic delay in IBM and non-IBM types of IIM
Fig. 5
Fig. 5
Subgroup analysis between gatekeeper and non-gatekeeper health systems

References

    1. Malik A, et al. Idiopathic inflammatory myopathies: clinical approach and management. Front Neurol. 2016;7:64–64. doi: 10.3389/fneur.2016.00064. - DOI - PMC - PubMed
    1. World Health Organization, International statistical classification of diseases and related health problems; 2019.
    1. Lilleker J, et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis. 2017;77:30–39. doi: 10.1136/annrheumdis-2017-211868. - DOI - PMC - PubMed
    1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts) N Engl J Med. 1975;292(7):344–347. doi: 10.1056/NEJM197502132920706. - DOI - PubMed
    1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. The Lancet. 2003;362(9388):971–982. doi: 10.1016/S0140-6736(03)14368-1. - DOI - PubMed

Publication types